US IPO news: Is ADARx Pharmaceuticals’ $446.3M Raise Worth It?
US IPO news reveals ADARx Pharmaceuticals raised $446.3 million in an upsized offering, showcasing strong investor interest.
US IPO news reveals ADARx Pharmaceuticals raised $446.3 million in an upsized offering, showcasing strong investor interest.